In COPD, persistent airway inflammation with chronically elevated IL-6 and TNF-α promotes protein degradation via the ubiquitin-proteasome system, muscle fiber type shifts, and mitochondrial dysfunction [13], resulting in sustained systemic inflammation, heightened infection susceptibility, and qualitative changes in immune responses. The gene discussed is IL6; the disease is chronic obstructive pulmonary disease.